Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 6 |
GO:0110165 | cellular anatomical entity | 1 | 6 |
Related structures:
AlphaFold database: Q4QD21
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 115 | 117 | PF00675 | 0.608 |
CLV_NRD_NRD_1 | 137 | 139 | PF00675 | 0.680 |
CLV_NRD_NRD_1 | 144 | 146 | PF00675 | 0.640 |
CLV_NRD_NRD_1 | 34 | 36 | PF00675 | 0.439 |
CLV_PCSK_KEX2_1 | 115 | 117 | PF00082 | 0.608 |
CLV_PCSK_KEX2_1 | 137 | 139 | PF00082 | 0.635 |
CLV_PCSK_KEX2_1 | 143 | 145 | PF00082 | 0.592 |
CLV_PCSK_KEX2_1 | 36 | 38 | PF00082 | 0.449 |
CLV_PCSK_PC1ET2_1 | 137 | 139 | PF00082 | 0.616 |
CLV_PCSK_PC1ET2_1 | 143 | 145 | PF00082 | 0.592 |
CLV_PCSK_PC1ET2_1 | 36 | 38 | PF00082 | 0.449 |
CLV_PCSK_SKI1_1 | 37 | 41 | PF00082 | 0.421 |
DEG_APCC_DBOX_1 | 115 | 123 | PF00400 | 0.403 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.781 |
DOC_USP7_UBL2_3 | 139 | 143 | PF12436 | 0.413 |
DOC_WW_Pin1_4 | 1 | 6 | PF00397 | 0.720 |
DOC_WW_Pin1_4 | 100 | 105 | PF00397 | 0.453 |
LIG_14-3-3_CanoR_1 | 37 | 45 | PF00244 | 0.641 |
LIG_FHA_2 | 15 | 21 | PF00498 | 0.678 |
LIG_FHA_2 | 54 | 60 | PF00498 | 0.747 |
LIG_LIR_Gen_1 | 70 | 80 | PF02991 | 0.507 |
LIG_LIR_Nem_3 | 70 | 76 | PF02991 | 0.491 |
LIG_PTB_Apo_2 | 88 | 95 | PF02174 | 0.527 |
LIG_PTB_Phospho_1 | 88 | 94 | PF10480 | 0.523 |
LIG_SH2_NCK_1 | 45 | 49 | PF00017 | 0.634 |
LIG_SH2_SRC | 9 | 12 | PF00017 | 0.774 |
LIG_SH2_STAP1 | 45 | 49 | PF00017 | 0.634 |
LIG_SH2_STAT5 | 108 | 111 | PF00017 | 0.497 |
LIG_SH2_STAT5 | 82 | 85 | PF00017 | 0.332 |
LIG_SH2_STAT5 | 9 | 12 | PF00017 | 0.747 |
LIG_TRAF2_1 | 51 | 54 | PF00917 | 0.657 |
MOD_CDC14_SPxK_1 | 103 | 106 | PF00782 | 0.451 |
MOD_CDK_SPxK_1 | 100 | 106 | PF00069 | 0.455 |
MOD_CK1_1 | 12 | 18 | PF00069 | 0.762 |
MOD_CK1_1 | 133 | 139 | PF00069 | 0.431 |
MOD_CK1_1 | 4 | 10 | PF00069 | 0.737 |
MOD_CK2_1 | 126 | 132 | PF00069 | 0.432 |
MOD_CK2_1 | 25 | 31 | PF00069 | 0.656 |
MOD_GSK3_1 | 12 | 19 | PF00069 | 0.692 |
MOD_GSK3_1 | 126 | 133 | PF00069 | 0.453 |
MOD_GSK3_1 | 21 | 28 | PF00069 | 0.671 |
MOD_N-GLC_1 | 100 | 105 | PF02516 | 0.676 |
MOD_NEK2_2 | 9 | 14 | PF00069 | 0.748 |
MOD_PIKK_1 | 53 | 59 | PF00454 | 0.743 |
MOD_PKA_1 | 37 | 43 | PF00069 | 0.632 |
MOD_PKA_2 | 25 | 31 | PF00069 | 0.656 |
MOD_PKB_1 | 35 | 43 | PF00069 | 0.632 |
MOD_Plk_4 | 126 | 132 | PF00069 | 0.409 |
MOD_Plk_4 | 4 | 10 | PF00069 | 0.701 |
MOD_ProDKin_1 | 1 | 7 | PF00069 | 0.718 |
MOD_ProDKin_1 | 100 | 106 | PF00069 | 0.455 |
MOD_SUMO_for_1 | 49 | 52 | PF00179 | 0.617 |
MOD_SUMO_rev_2 | 59 | 64 | PF00179 | 0.724 |
TRG_ENDOCYTIC_2 | 72 | 75 | PF00928 | 0.327 |
TRG_ER_diArg_1 | 144 | 146 | PF00400 | 0.486 |
TRG_ER_diArg_1 | 34 | 37 | PF00400 | 0.639 |
TRG_NES_CRM1_1 | 117 | 132 | PF08389 | 0.439 |
TRG_NLS_MonoCore_2 | 34 | 39 | PF00514 | 0.645 |
TRG_NLS_MonoExtC_3 | 35 | 41 | PF00514 | 0.641 |
TRG_NLS_MonoExtN_4 | 35 | 40 | PF00514 | 0.637 |
TRG_Pf-PMV_PEXEL_1 | 37 | 41 | PF00026 | 0.428 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P526 | Leptomonas seymouri | 89% | 76% |
A0A0S4JEM4 | Bodo saltans | 57% | 100% |
A0A1X0NWZ6 | Trypanosomatidae | 77% | 79% |
A0A3S7WVT3 | Leishmania donovani | 99% | 100% |
A0A422NEH4 | Trypanosoma rangeli | 74% | 81% |
A4HYL4 | Leishmania infantum | 99% | 100% |
E9AI77 | Leishmania braziliensis | 95% | 100% |
E9AUG3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 98% | 100% |